F · Healthcare

LWB1 (LWB1)

Biotechnology

LWB1 (LWB1) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $1.58B, P/E ratio is 18.00, net margin is -144.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for LWB1

Market cap
$1.58B
P/E ratio
18.00
Gross profit (TTM)
$-23.23M
Net margin
-144.3%

LWB1 (LWB1) — FAQ

What is LWB1's market cap?

LWB1 (LWB1) has a reported market cap of $1.58B (data as of 2026-03-30).

What is LWB1's P/E ratio?

The price-to-earnings (P/E) ratio for LWB1 (LWB1) is 18.00 (data as of 2026-03-30).

Does LWB1 pay a dividend?

Dividend yield is not available in the current snapshot for LWB1 (LWB1). Check the MyAverix Finance app for the latest dividend data.

What sector is LWB1 in?

LWB1 (LWB1) is classified in the Healthcare sector (Biotechnology industry).

What exchange is LWB1 listed on?

LWB1 is listed on F.

What is LWB1's net margin?

LWB1 (LWB1) reports a net margin of -144.3% (data as of 2026-03-30).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play